Alternatives to Twig Bio

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing next-generation mRNA medicines.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

A biotechnology company focused on oncology drug discovery.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

UK biotechnology company developing sustainable natural rubber from engineered dandelions.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.